文献速递胃肠外科

D2淋巴结清扫联合完整胃系膜切除治疗胃癌的短期结局:倾向性评分匹配分析

Short-term outcomes of D2 lymphadenectomy plus complete mesogastric excision for gastric cancer: a propensity score matching analysis.
PubMed 文献 · Surg Endosc · 2022-05-31

该研究基于855例接受腹腔镜辅助远端胃切除术且R0切除的胃癌患者数据,经1:1倾向性评分匹配后每组219例,比较D2+CME与传统D2的短期结局。结果显示D2+CME组术中出血更少、淋巴结收获更多、术后排气更快,而总体和严重术后不良事件(Clavien-Dindo分级≥IIIa)两组似乎相当。结论认为D2+CME与更好的短期结局相关。

要点

  • D2+CME组术中出血少于传统D2组。
  • D2+CME组淋巴结收获多于传统D2组。
  • D2+CME组术后排气快于传统D2组。

核心结论

  • 对于可切除胃癌患者,D2+CME与传统D2清扫相比与更好的短期结局相关。

研究设计与样本

  • 大规模观察性队列研究,数据来自同济医院前瞻性维护的临床数据库。
  • 纳入2013年12月12日至2017年12月28日期间接受腹腔镜辅助远端胃切除术且R0切除的855例胃癌患者,其中传统D2组496例,D2+CME组359例。
  • 采用1:1倾向性评分匹配分析后,每组各219例匹配患者。

主要发现

  • D2+CME组术中腹腔内出血少于传统D2组。
  • D2+CME组淋巴结收获多于传统D2组。
  • D2+CME组术后排气快于传统D2组。
  • 两组总体术后不良事件和严重术后不良事件(Clavien-Dindo分级≥IIIa)似乎相当。

临床怎么用

  • 在可切除胃癌的腹腔镜辅助远端胃切除术中,D2+CME可能减少术中出血并增加淋巴结收获、促进术后排气。

局限性

  • 本研究为观察性队列研究,即使采用倾向性评分匹配,仍可能存在未测量的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our previous study has demonstrated the surgical advantages of D2 lymphadenectomy plus complete mesogastric excision (D2 + CME) in gastric cancer surgery. To further verify the safety of D2 + CME procedure, we conducted this large-scale, observational cohort study and applied propensity score matching (PSM) approach to compare D2 + CME with conventional D2 in terms of short-term outcomes in gastric cancer patients. METHODS: Data on 855 patients from Tongji Hospital who underwent laparoscopic-assisted distal gastrectomy (LADG) with R0 resection (496 in the conventional D2 cohort and 359 in the D2 + CME cohort) between Dec 12, 2013 and Dec 28, 2017 were retrieved from prospectively maintained clinical database. After PSM analysis at a 1:1 ratio, each cohort included 219-matched patients. Short-term outcomes, including surgical results, morbidity, and mortality within 30 days after the operation, were collected and analyzed. RESULTS: In this large-scale, observational cohort study based on PSM analysis, the D2 + CME procedure showed less intra-laparoscopic blood loss, more lymph node harvest, and faster postoperative flatus than the conventional D2 procedure. However, both the overall and severe postoperative adverse events (Clavien-Dindo classification grade ≥ III a) seemed comparable between two cohorts. CONCLUSION: The present study showed that D2 + CME was associated with better short-term outcomes than conventional D2 dissection for patients with resectable gastric cancer.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zhao D, Deng J, Cao B, et al. Short-term outcomes of D2 lymphadenectomy plus complete mesogastric excision for gastric cancer: a propensity score matching analysis. Surg Endosc. 2022. PMID: 35641697. doi:10.1007/s00464-022-09092-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。